Atlas Trials

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Clinical trial NCT03986515 · UNKNOWN

Trial details

NCT number
NCT03986515
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Mucosal MelanomaAdvanced CancerApatinibSHR-1210
Start date
2019-06-04
Primary completion
2021-05-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.